Search

everythinglearnresearchcommunity

for

Search:↓

The study found no significant link between the symptoms, tissue analysis, and immunofluorescence results in scarring hair loss conditions.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

Lack of Evi in skin causes psoriasis-like symptoms in mice.

Increasing the levels of a protein called FGF9 can promote hair growth, but humans may not respond the same way due to a lack of certain cells.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Alopecia areata causes hair loss and affects mental health, with new treatments like JAK inhibitors offering hope.

Alopecia areata causes hair loss and affects mental health, with new treatments like JAK inhibitors offering hope.

Scalp psoriasis is a chronic condition that can be managed with treatments like corticosteroids and salicylic acid.

Blocking the CXCL12–CXCR4 axis may help treat hair loss in alopecia.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Belatacept may be a promising treatment for alopecia areata.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Angelica sinensis helps repair and regenerate the thymus in mice.

Alopecia areata causes unpredictable hair loss and requires personalized treatment.

Female-pattern hair loss may involve an autoimmune-like process, suggesting new treatment options.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

Androgenetic alopecia in males is linked to significant psychological distress, highlighting the need for both mental and dermatological care.

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Stress can cause hair loss and trigger autoimmunity by damaging hair follicle cells.

Exosomes from certain cells can improve hair regrowth by changing the immune response.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Thymoma with alopecia areata may be linked to abnormal immune cells.

Immune system changes may contribute to female pattern hair loss.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.